Reuters logo
BRIEF-Adaptimmune Therapeutics Plc announces initiation of triple tumor study
2016年10月18日 / 下午12点42分 / 1 年前

BRIEF-Adaptimmune Therapeutics Plc announces initiation of triple tumor study

Oct 18 (Reuters) - Adaptimmune Therapeutics Plc :

* Adaptimmune Therapeutics Plc - adaptimmune announces initiation of triple tumor study to evaluate its spear t-cell therapy targeting MAGE-A10 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below